Heart Disease
Medline Studies
Scientific Studies
Oral EDTA
Competitive Products
Toxic Metals
Main Technical Section For  Chelation Therapy On Line

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Heart Disease & Bypass Surgery Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help

Karl Loren Background

Ingredients
Technical
Write To Karl Loren Table Of Contents

31 Studies:  Chemical Interaction with Mercury and EDTA


Results for your query on September 3, 2000:
Search all fields for: mercury And EDTA
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans

Documents: 1 to 31 of 31

1

Top Of Menu

Duhr EF, et al; HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. (Toxicol Appl Pharmacol, 1993 Oct, Abstract available) [MEDLINE]

2 Kalamegham R, et al; A simple ICP-MS procedure for the determination of total mercury in whole blood and urine. (J Clin Lab Anal, 1992, Abstract available) [MEDLINE]
3 Gonzalvo MC, et al; Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. (Chem Biol Interact, 1997 Aug, Abstract available) [MEDLINE]
4 Mujica A, et al; Human semen ribonuclease. Location, properties and inhibition by sodium dodecyl sulfate, zinc sulfate and EDTA. (Int J Fertil, 1976, Abstract available) [MEDLINE]
5 Farkas WR, et al; Effects of plumbous ion on guanine metabolism. (J Inorg Biochem, 1979 Aug, Abstract available) [MEDLINE]
6 Guldager B, et al; Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA. (Clin Chem, 1996 Dec, Abstract available) [MEDLINE]
7 Duhr EF, et al; HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. (Toxicol Appl Pharmacol, 1993 Oct, Abstract available) [MEDLINE]
8 Nooijen JL, et al; Trace element studies in three patients and a fetus with Menkes' disease. Effect of copper therapy. (Pediatr Res, 1981 Mar, Abstract available) [MEDLINE]
9 Chau LY, et al; Monoglyceride and diglyceride lipases from human platelet microsomes. (Biochim Biophys Acta, 1988 Dec, Abstract available) [MEDLINE]
10

Menu Position #10

Murata M, et al; Differential metal response and regulation of human heavy metal-inducible genes. (J Cell Physiol, 1999 Jul, Abstract available) [MEDLINE]

11 Araki S, et al; Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators. (Br J Ind Med, 1986 Sep, Abstract available) [MEDLINE]
12 Kumar S, et al; Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells. (Cancer Res, 1975 Jan, Abstract available) [MEDLINE]
13 Mitchell RA, et al; Erythrocyte porphobilinogen synthase (delta-aminolaevulinate dehydratase) activity: a reliable and quantitative indicator of lead exposure in humans. (Clin Chem, 1977 Jan, Abstract available) [MEDLINE]
14 Noma A, et al; Comparative studies on cholesterol oxidases from different sources. (Clin Chim Acta, 1976 Dec, Abstract available) [MEDLINE]
15 Warwas M, et al; Cathepsins B1 from human fetal membranes. (Biochim Biophys Acta, 1976 Apr, Abstract available) [MEDLINE]
16 Dunbabin DW, et al; Lead poisoning from Indian herbal medicine (Ayurveda) [see comments] (Med J Aust, 1992 Dec, Abstract available) [MEDLINE]
17 Alton KB, et al; High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric detector. (J Chromatogr, 1992 Sep, Abstract available) [MEDLINE]
18 Szász I, et al; Phosphorylation of the Ca2+ pump intermediate in intact red cells, isolated membranes and inside-out vesicles. (Mol Cell Biochem, 1978 Dec, Abstract available) [MEDLINE]
19 Margel S; A novel approach for heavy metal poisoning treatment, a model. Mercury poisoning by means of chelating microspheres: hemoperfusion and oral administration. (J Med Chem, 1981 Oct, Abstract available) [MEDLINE]
20

Menu Position #20

Sandborgh Englund G, et al; No evidence of renal toxicity from amalgam fillings [see comments] (Am J Physiol, 1996 Oct, Abstract available) [MEDLINE]

21 Pratt CW, et al; The effect of zinc and other divalent cations on the structure and function of human alpha 2-macroglobulin. (Biochim Biophys Acta, 1984 Dec, Abstract available) [MEDLINE]
22 De Bisschop HC, et al; Stereoselective hydrolysis of soman in human plasma and serum. (Biochem Pharmacol, 1987 Nov, Abstract available) [MEDLINE]
23 Aposhian HV, et al; Mobilization of heavy metals by newer, therapeutically useful chelating agents. (Toxicology, 1995 Mar, Abstract available) [MEDLINE]
24 Hainaut P, et al; A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. (Cancer Res, 1993 Apr, Abstract available) [MEDLINE]
25 Hainaut P, et al; A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. (Cancer Res, 1993 Apr, Abstract available) [MEDLINE]
26 ten Bruggenkate CM, et al; Lead poisoning with pigmentation of the oral mucosa. Review of the literature and report of a case. (Oral Surg Oral Med Oral Pathol, 1975 May, Abstract available) [MEDLINE]
27 Teng YS, et al; Human erythrocyte pyrimidine nucleoside monophosphate kinase. Partial purification and properties of two allelic gene products. (J Biol Chem, 1976 Jul, Abstract available) [MEDLINE]
28 Aaseth J; Recent advance in the therapy of metal poisonings with chelating agents. (Hum Toxicol, 1983 Apr, Abstract available) [MEDLINE]
29 Domingo JL; Prevention by chelating agents of metal-induced developmental toxicity. (Reprod Toxicol, 1995 Mar, Abstract available) [MEDLINE]
30

Menu Position #30

Rabel SR, et al; Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection. (Anal Biochem, 1995 Jan, Abstract available) [MEDLINE]

31 Shatzman AR, et al; Metal-binding characteristics of the parotid salivary protein gustin. (Biochim Biophys Acta, 1980 May, Abstract available) [MEDLINE]


Click here for more information!  

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.


     

Record 1 from database: MEDLINE
Return To Top

Title
HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin.
Author
Duhr EF; Pendergrass JC; Slevin JT; Haley BE
Address
Division of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Kentucky Medical Center, Lexington.
Source
Toxicol Appl Pharmacol, 1993 Oct, 122:2, 273-80
Abstract
We have found that EDTA and EGTA complexes of Hg2+, which conventional wisdom has assumed are biologically inert, are potentially injurious to the neuronal cytoskeleton. Tubulin, a major protein component of the neuronal cytoskeleton, is the target of multiple toxicants, including many heavy metal ions. Among the mercurials, inorganic mercuric ion (Hg2+) is one of the most potent inhibitors of microtubule polymerization both in vivo and in vitro. In contrast to other heavy metals, the capacity of Hg2+ to inhibit microtubule polymerization or disrupt formed microtubules cannot be prevented by the addition of EDTA and EGTA, both of which bind Hg2+ with very high affinity. To the contrary, the addition of these two chelating agents potentiates Hg2+ inhibition of tubulin polymerization. Results herein show that HgEDTA and HgEGTA inhibit tubulin polymerization by disrupting the interaction of GTP with the E-site of brain beta-tubulin, an obligatory step in the polymerization of tubulin. Both HgEDTA and HgEGTA, but not free Hg2+, prevented binding of [32P]8N3GTP, a photoaffinity nucleotide analog of GTP, to the E-site and displaced bound [32P]8N3GTP at low micromolar concentrations. This complete inhibition of photoinsertion into the E-site occurred in a concentration- and time-dependent fashion and was specific for Hg2+ complexes of EDTA and EGTA, among the chelating agents tested. Given the ubiquity of Hg2+ in the environment and the widespread use of EDTA in foodstuffs and medicine, these mercury complexes may pose a potentially serious threat to human health and play a role in diseases of the neuronal cytoskeleton.
Language of Publication
English
Unique Identifier
94024905

Return To Top


MeSH Heading (Major)
Brain|*DE/ME; Edetic Acid|*PD; Guanosine Triphosphate|AA/DU/*ME; Mercury|*PD; Tubulin|*DE/ME
MeSH Heading
Affinity Labels|DU; Animal; Azides|DU; Binding Sites|DE; Human; In Vitro; Magnesium|PD; Male; Phosphorus Radioisotopes|DU; Photochemistry; Protein Binding|DE; Rats; Rats, Sprague-Dawley; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0041-008X
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
A simple ICP-MS procedure for the determination of total mercury in whole blood and urine.
Author
Kalamegham R; Ash KO
Address
Department of Pathology, University of Utah Medical Center, Salt Lake City 84108.
Source
J Clin Lab Anal, 1992, 6:4, 190-3
Abstract
A simple and sensitive procedure for total mercury in whole blood and urine using inductively coupled plasma-mass spectrometry (ICP-MS) is described. Specimens are prepared by precipitation-extraction with 50% v/v hydrochloric acid containing EDTA and cysteine, centrifuged, and filtered through fritended screening column; the filtrates are directly analyzed by ICP-MS. The method is linear between 2 and 200 micrograms/L in the specimen with an absolute sensitivity of 0.2 microgram/L in the final supernatant. The assay variability at various concentrations (microgram/L) of mercury are as follows: intra-assay whole blood (n = 20)-4.6 +/- 0.6 (c.v. 12.3%), 18.3 +/- 1.1 (c.v. 6.1%), 56.4 +/- 2.8 (c.v. 5.0%); inter-assay whole blood (n = 15)-5.7 +/- 1.0 (c.v. 16.8%), 19.7 +/- 2.7 (c.v. 13.5%), and 50.1 +/- 6.9 (c.v. 13.7%); urine (n = 20)-9.3 +/- 1.2 (c.v. 12.9%), 29.6 +/- 2.2 (c.v. 7.4%). Recovery of organic and inorganic mercury from blood samples ranges from 91.6% to 110.2%. The method is suitable for analysis of total mercury, both organic and inorganic, in whole blood and urine.
Language of Publication
English
Unique Identifier
93019810

Return To Top


MeSH Heading (Major)
Mercury|*BL/*UR; Spectrum Analysis, Mass|*MT/SN
MeSH Heading
Argon; Cysteine; Edetic Acid; Human; Hydrochloric Acid; Methylmercury Compounds|BL/UR; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0887-8013
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials.
Author
Gonzalvo MC; Gil F; Hernández AF; Villanueva E; Pla A
Address
Department of Legal Medicine, Faculty of Medicine, Granada, Spain.
Source
Chem Biol Interact, 1997 Aug, 105:3, 169-79
Abstract
Inhibition of paraoxon hydrolase (paraoxonase) activity by 'in vitro' exposure to EDTA, Mg2+, Co2+, Ba2+, La3+, Zn2+, Cu2+, Hg2+, p-hydroxymercuribenzoate (p-OH-MB) and phenyl mercuric acetate (PMA) was investigated in human liver microsomes. Enzyme activity was totally inhibited by 1 mM EDTA in a time-dependent manner, in contrast to previous data obtained in rat liver where an EDTA-resistant fraction was detected. The possible influence of postmortem changes in these results was checked in a parallel experiment using rat livers with different postmortem intervals. From our results the existence in human liver of an EDTA-resistant fraction cannot be discarded. Ba, La and PMA showed immediate inhibition. By contrast the other compounds tested were time-dependent inhibitors. Ba and Zn showed the highest IC50 values. Cu and mercurials (Hg, p-OH-MB, PMA) were the most potent inhibitors of human liver paraoxonase. Kinetic analysis (Lineweaver-Burk and Dixon plots) indicated that different inhibitors exhibit different inhibition patterns: competitive (EDTA, Ba, La, Cu, p-OH-MB and PMA), non competitive (Zn) and mixed (Hg). The pretreatment of sample with dithiothreitol (DTT) protects against the inhibitory effect of mercurials. Furthermore after inhibition by mercurials the activity was restored by DTT. These results confirmed the essential role of the -SH groups to maintain the catalytic activity of paraoxonase and suggest the existence of two types of -SH groups that could differ in their localization.
Language of Publication
English
Unique Identifier
97437462

Return To Top


MeSH Heading (Major)
Edetic Acid|*PD; Enzyme Inhibitors|*PD; Esterases|*AI/ME; Mercury Compounds|*PD; Metals|*PD; Microsomes, Liver|DE/*EN
MeSH Heading
Animal; Dithiothreitol|PD; Enzyme Activation; Human; Kinetics; Rats; Sulfhydryl Compounds|ME; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0009-2797
Country of Publication
IRELAND

Record 4 from database: MEDLINE
Return To Top

Title
Human semen ribonuclease. Location, properties and inhibition by sodium dodecyl sulfate, zinc sulfate and EDTA.
Author
Mujica A; Romero G; Hernandez Montes H
Address
 
Source
Int J Fertil, 1976, :2, 109-13
Abstract
Optimal conditions were established for RNase activity measurement. The enzyme was measured in human seminal plasma as well as in spermatozoa. Results suggest that sperm enzyme may come from seminal plasma contamination and that RNase may be used as a marker enzyme for seminal plasma contamination. Sodium dodecylsulfate, a reagent utilized to produce the solubilization of the spermatozoa, produced a very strong inhibition of the RNase at low concentrations (530 muM). Zinc sulfate and EDTA also produced inhibition of the RNase activity. Such inhibition may be very useful in future studies of RNA metabolism in human spermatozoa.
Language of Publication
English
Unique Identifier
76259358

Order full text for this document


MeSH Heading (Major)
Edetic Acid|*PD; Ribonucleases|*/ME; Semen|*EN; Sodium Dodecyl Sulfate|*PD; Zinc|*PD
MeSH Heading
Dithiothreitol|PD; Human; Hydrogen-Ion Concentration; Male; Mercury|PD; Spermatozoa|EN

Publication Type
JOURNAL ARTICLE
ISSN
0020-725X
Country of Publication
UNITED STATES

Record 5 from database: MEDLINE
Return To Top

Title
Effects of plumbous ion on guanine metabolism.
Author
Farkas WR; Stanawitz T
Address
 
Source
J Inorg Biochem, 1979 Aug, 11:1, 31-8
Abstract
The enzyme guanine aminohydrolase (guanase) is inhibited by low levels of Pb2+. The inhibition is noncompetitive and the Ki is 3.0 X 10(-6) M. The only other heavy metals that are inhibitory at low concentrations are Ag+, which is 36% more, and Hg2+, which is about 50% less inhibitory than Pb2+. The inhibition of guanase by Pb2+ and Hg2+ is synergistic and the inhibition of the enzyme was readily reversed by EDTA. The relationship of these studies with guanase and to the etiology and treatment of saturnine gout, which appears in humans suffering from lead poisoning, is discussed.
Language of Publication
English
Unique Identifier
80008188

Return To Top


MeSH Heading (Major)
Aminohydrolases|*AI; Guanine Deaminase|*AI; Lead|*PD
MeSH Heading
Cations, Divalent; Edetic Acid|PD; Gout|EN/ET; Human; Kinetics; Lead Poisoning|EN; Mercury|PD; Silver|PD; Support, U.S. Gov't, P.H.S.; Xanthine Oxidase|ME

Publication Type
JOURNAL ARTICLE
ISSN
0162-0134
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA.
Author
Guldager B; J‡rgensen PJ; Grandjean P
Address
Department of Surgery, Hiller‡d Hospital, Denmark.
Source
Clin Chem, 1996 Dec, 42:12, 1938-42
Abstract
Sixty patients with intermittent claudication participated in a double-blind placebo-controlled trial of 20 courses of intravenous chelation therapy with 3 g of disodium EDTA vs placebo during 5-9 weeks. After the first infusion, the 24-h urinary excretion of lead and zinc was approximately 25-fold higher in the EDTA-treated group; relative differences for copper and calcium were smaller. Urinary magnesium excretion in the EDTA-treated group was one-third less than in the control group. After the treatment period, the blood lead concentration had decreased by approximately 73% and the serum zinc concentration by approximately 34%; other changes in blood concentrations were negligible. The loss of essential minerals and the possible redistribution of lead in the body may constitute a disadvantage that should be taken into account in repeated intravenous EDTA treatment.
Language of Publication
English
Unique Identifier
97124459

Return To Top


MeSH Heading (Major)
Edetic Acid|*TU; Intermittent Claudication|*DT/ME; Magnesium|BL/*ME/UR; Metals|*UR
MeSH Heading
Adult; Aged; Aged, 80 and over; Calcium|UR; Copper|BL/UR; Double-Blind Method; Human; Lead|BL/UR; Mercury|BL; Middle Age; Placebos; Support, Non-U.S. Gov't; Zinc|BL/UR

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
ISSN
0009-9147
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin.
Author
Duhr EF; Pendergrass JC; Slevin JT; Haley BE
Address
Division of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Kentucky Medical Center, Lexington.
Source
Toxicol Appl Pharmacol, 1993 Oct, 122:2, 273-80
Abstract
We have found that EDTA and EGTA complexes of Hg2+, which conventional wisdom has assumed are biologically inert, are potentially injurious to the neuronal cytoskeleton. Tubulin, a major protein component of the neuronal cytoskeleton, is the target of multiple toxicants, including many heavy metal ions. Among the mercurials, inorganic mercuric ion (Hg2+) is one of the most potent inhibitors of microtubule polymerization both in vivo and in vitro. In contrast to other heavy metals, the capacity of Hg2+ to inhibit microtubule polymerization or disrupt formed microtubules cannot be prevented by the addition of EDTA and EGTA, both of which bind Hg2+ with very high affinity. To the contrary, the addition of these two chelating agents potentiates Hg2+ inhibition of tubulin polymerization. Results herein show that HgEDTA and HgEGTA inhibit tubulin polymerization by disrupting the interaction of GTP with the E-site of brain beta-tubulin, an obligatory step in the polymerization of tubulin. Both HgEDTA and HgEGTA, but not free Hg2+, prevented binding of [32P]8N3GTP, a photoaffinity nucleotide analog of GTP, to the E-site and displaced bound [32P]8N3GTP at low micromolar concentrations. This complete inhibition of photoinsertion into the E-site occurred in a concentration- and time-dependent fashion and was specific for Hg2+ complexes of EDTA and EGTA, among the chelating agents tested. Given the ubiquity of Hg2+ in the environment and the widespread use of EDTA in foodstuffs and medicine, these mercury complexes may pose a potentially serious threat to human health and play a role in diseases of the neuronal cytoskeleton.
Language of Publication
English
Unique Identifier
94024905

Return To Top


MeSH Heading (Major)
Brain|*DE/ME; Edetic Acid|*PD; Guanosine Triphosphate|AA/DU/*ME; Mercury|*PD; Tubulin|*DE/ME
MeSH Heading
Affinity Labels|DU; Animal; Azides|DU; Binding Sites|DE; Human; In Vitro; Magnesium|PD; Male; Phosphorus Radioisotopes|DU; Photochemistry; Protein Binding|DE; Rats; Rats, Sprague-Dawley; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0041-008X
Country of Publication
UNITED STATES

Record 8 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Trace element studies in three patients and a fetus with Menkes' disease. Effect of copper therapy.
Author
Nooijen JL; De Groot CJ; Van den Hamer CJ; Monnens LA; Willemse J; Niermeijer MF
Address
 
Source
Pediatr Res, 1981 Mar, 15:3, 284-9
Abstract
This paper reports the results of a multielement analysis of postmortem samples of Menkes patients, of which one was untreated and two had been treated for various lengths of time with intramuscular injections of copper-EDTA. The findings have been compared with data from a Menkes fetus and from controls. The results confirm that copper accumulates in various tissues and demonstrate a further increase in copper levels as a result of the treatment with copper-EDTA. Although no clinical improvement was observed, the levels of some copper-containing enzymes normalized during the copper-therapy. Furthermore, in agreement with the identification of the copper-binding protein in the kidney as metallothionein, it was found that not only copper, but also zinc, cadmium, and mercury are trapped in this tissue. A low copper concentration in the brain was also found in a Menkes fetus, indicating that brain damage might already have occurred before birth. Speculation Until recently, Menkes' disease was considered to be due to copper deficiency. However, the symptoms are more typical of a storage disease in which copper is irreversibly trapped in some tissues, in particular in the kidneys, by metallothionein. This abnormal storage pattern gives rise to copper deficiency elsewhere in the organism, particularly in the brain where it may cause irreversible damage in the foetus. Parenteral administration of copper does not lead to clinical improvement. The only "therapy" that seems feasible at present is tracing the carriers of the disease and advising abortion when prenatal diagnosis indicates a male fetus carrying the disease.
Language of Publication
English
Unique Identifier
81174435

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Brain Diseases, Metabolic|*DT; Copper|AN/*TU; Menkes Kinky Hair Syndrome|DI/*DT; Trace Elements|*AN
MeSH Heading
Arsenic|AN; Cadmium|AN; Case Report; Cobalt|AN; Comparative Study; Edetic Acid; Female; Fetal Diseases|DI; Human; Infant; Iron|AN; Male; Mercury|AN; Molybdenum|AN; Pregnancy; Selenium|AN; Tissue Distribution; Zinc|AN

Publication Type
JOURNAL ARTICLE
ISSN
0031-3998
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Monoglyceride and diglyceride lipases from human platelet microsomes.
Author
Chau LY; Tai HH
Address
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Kentucky, Lexington 405367-0082.
Source
Biochim Biophys Acta, 1988 Dec, 963:3, 436-44
Abstract
In the present study, we have characterized the properties of both diglyceride lipase (lipoprotein lipase, EC 3.1.1.24) and monoglyceride lipases (acylglycerol lipase, EC 3.1.1.23) in an attempt to assess the potential roles of these two enzymes in the release of arachidonate in activated human platelets. Diglyceride lipase exhibited maximal activity at pH 3.5, whereas monoglyceride lipase showed optimal activity at pH 7.0. Neither of the lipases were inhibited by EDTA or stimulated by Ca2+, Mg2+ or Mn2+. Both enzymes, however, were strongly inhibited by Hg2+ and Cu2+, indicating the involvement of sulfhydryl groups in catalytic activity. This suggestion was further supported by their sensitivity toward sulfhydryl inhibitors, with monoglyceride lipase being more susceptible to inhibition. Both lipases were found to be inhibited to a different degree by a variety of antiplatelet drugs blocking aggregation and arachidonate release. Kinetic studies indicated that dichotomous metabolism of diacylglycerol to monoacylglycerol and to phosphatidic acid could occur concurrently, since the apparent Km values for diglyceride lipase and for diglyceride kinase were comparable. Further studies showed that the specific activity of monoglyceride lipase was at least 100-fold higher than that of diglyceride lipase, indicating that the rate-limiting step in the release of arachidonate was the reaction catalyzed by diglyceride lipase.
Language of Publication
English
Unique Identifier
89062521

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Platelets|*EN; Carboxylic Ester Hydrolases|*BL; Lipoprotein Lipase|*BL; Monoacylglycerol Lipases|*BL
MeSH Heading
Calcium|PD; Copper|PD; Edetic Acid|PD; Heat; Human; Hydrogen-Ion Concentration; Kinetics; Magnesium|PD; Manganese|PD; Mercury|PD; Microsomes|EN; Platelet Aggregation Inhibitors|PD; Substrate Specificity; Sulfhydryl Reagents|PD; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Record 10 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Differential metal response and regulation of human heavy metal-inducible genes.
Author
Murata M; Gong P; Suzuki K; Koizumi S
Address
Division of Hazard Assessment, National Institute of Industrial Health, Kawasaki, Japan.
Source
J Cell Physiol, 1999 Jul, 180:1, 105-13
Abstract
A number of heavy metal-inducible genes have been reported, but their ranges of response to various metal species are not well known. It is also unclear if these genes are regulated through common mechanisms. To answer these questions, we compared induction kinetics of human metal-inducible genes including the MT-IIA (coding for a metallothionein isoform), hsp70 (coding for the 70-kDa heat-shock protein), and c-fos genes in HeLa cells exposed to Zn, Cd, Ag, Hg, Cu(II), Co, or Ni ions. Transcripts from these three genes were increased after exposure to wide ranges of metals, but each gene was unique in its induction kinetics. Generally, induction was observed at lower metal concentrations in the order of MT-IIA, hsp70, and c-fos. These genes also showed differential responses in time course: more rapid induction was observed in the order of c-fos, hsp70, and MT-IIA after exposure to Zn or Cd. Since the metal-responsive element (MRE) and heat shock element (HSE) of the MT-IIA and hsp70 genes, respectively, are thought to be the cis-acting DNA elements that mediate metal response, we compared the properties of proteins that specifically bind to these elements. MRE-binding activity was detected only in the extract from cells exposed to Zn. By contrast, HSE-binding activity was detected in extracts from cells treated with Zn, Cd, Ag, and Cu. The former was also activated by Zn in vitro, while the latter was not. Each of these DNA-binding activities showed no affinity to the recognition sequence of the other. These results demonstrate that the human metal-inducible genes have broad ranges of response to a variety of heavy metals, but suggest that they are probably regulated through independent mechanisms.
Language of Publication
English
Unique Identifier
99288869

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Heat-Shock Proteins 70|*GE; Metallothionein|*GE; Metals, Heavy|*PD; Proto-Oncogene Proteins c-fos|*GE
MeSH Heading
Blotting, Northern; Cadmium|PD; Chelating Agents|PD; Cobalt|PD; Copper|PD; Dose-Response Relationship, Drug; DNA-Binding Proteins|ME; Edetic Acid|PD; Gene Expression|DE; Gold|PD; Hela Cells; Human; Mercury|PD; Nickel|PD; Nuclear Proteins|ME; Oligonucleotide Probes; RNA, Messenger|AN; Transcription Factors|ME; Transcription, Genetic|PH; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0021-9541
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators.
Author
Araki S; Aono H; Murata K
Address
 
Source
Br J Ind Med, 1986 Sep, 43:9, 636-41
Abstract
To investigate the effects of calcium disodium ethylenediamine tetra-acetate (CaEDTA) on the urinary excretion, erythrocyte, and plasma concentrations and exposure indicators of seven heavy metals, CaEDTA was administered by intravenous infusion to 20 workers exposed to lead, zinc, and copper. The workers' blood lead concentrations ranged from 22 to 59 micrograms/dl (mean 38 micrograms/dl (1.8 mumol/l]. The 24 hour urinary excretion of metals after CaEDTA administration (mobilisation yield) was on average 13 times the background excretion for lead, 11 times for zinc, 3.8 times for manganese, 3.4 times for cadmium, 1.3 times for copper, and 1.1 times for chromium; no significant increase was found for mercury. The mobilisation yield of lead (MPb) was significantly correlated with whole blood and erythrocyte concentrations and the urinary excretion of lead but not with its plasma concentration; similarly, the mobilisation yield of cadmium was significantly correlated with its erythrocyte concentration. In addition, MPb was significantly correlated with intra-erythrocytic enzyme delta-aminolaevulinic acid dehydratase activity and urinary coproporphyrin excretion. The relation between the mobilisation yield of heavy metals and their body burden (and toxic signs) is discussed in the light of these findings.
Language of Publication
English
Unique Identifier
87000506

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Edetic Acid|*PD; Erythrocytes|*ME; Metals|*ME
MeSH Heading
Adult; Cadmium|ME; Chromium|ME; Copper|ME; Environmental Exposure; Human; Lead|ME; Male; Manganese|ME; Mercury|ME; Middle Age; Zinc|ME

Publication Type
JOURNAL ARTICLE
ISSN
0007-1072
Country of Publication
ENGLAND

Record 12 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
Author
Kumar S; Becker G; Prasad KN
Address
 
Source
Cancer Res, 1975 Jan, 35:1, 82-7
Abstract
The regulation of cyclic adenosine 3:5-monophosphate (cyclic AMP) phosphodiesterase activity in homogenates of malignant and cyclic AMP-induced "differentiated" neuroblastoma cells was studied. Neuroblastoma cells of at least three mouse and one human clone had both the low (2 to 4 muM) and the high (66 to 106 muM) Km phosphodiesterase. In cyclic AMP-induced differentiated cells the values of Km were decreased, whereas the values of Vmax appeared to be slightly increased. Magnesium and manganese stimulated phosphodiesterase activity. Calcium, zinc, copper, mercury, ethylenediaminetetraacetic acid, and imidazole completely inhibited phosphodiesterase activity in malignant cells, whereas the above agents, except ethylenediaminetetraacetic acid, only partially inhibited enzyme activity in differentiated cells. Ethylenediaminetetraacetic acid completely reduced phosphodiesterase activity in differentiated cells. The pH optimum for phosphodiesterase activity was about 8 in both malignant and differentiated cells. The present studies show that the values of Km and Vmax and the sensitivity of phosphodiesterase activity to divalent ions change in cyclic AMP-induced differentiated neuroblastoma cells, and therefore we propose that the reverse may be true during malignant transformation of nerve cells.
Language of Publication
English
Unique Identifier
75074120

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cell Differentiation|*; Cyclic AMP|ME/*PD; Neuroblastoma|*EN; Phosphoric Diester Hydrolases|*ME
MeSH Heading
Adenylate Cyclase|ME; Animal; Calcium|PD; Caudate Nucleus|EN; Clone Cells; Copper|PD; Depression, Chemical; Edetic Acid|PD; Human; Hydrogen-Ion Concentration; Imidazoles|PD; Magnesium|PD; Manganese|PD; Mercury|PD; Mice; Stimulation, Chemical; Support, U.S. Gov't, Non-P.H.S.; Time Factors; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Erythrocyte porphobilinogen synthase (delta-aminolaevulinate dehydratase) activity: a reliable and quantitative indicator of lead exposure in humans.
Author
Mitchell RA; Drake JE; Wittlin LA; Rejent TA
Address
 
Source
Clin Chem, 1977 Jan, 23:1, 105-11
Abstract
We assessed optimal conditions for assay of porphobillinogen synthase (EC 4.2.1.24) activity in human blood containing abnormally high concentrations of lead. Zn2+and -SH, both required for complete activation of the enzyme, had additive effects. Using a modified method based on these studies, we found blood lead concentration to be strictly proportional to ln(activated/nonactivated) enzyme activity. One brand of commercially available "lead-free" tubes contained a substance that interfered with this relationship. In vitro studies, with the modified assay, showed ALAD to be activated by low concentrations but inactivated by high concentrations of Hg2+, Cd2+, and ethylenediaminetetraacetate. We fouund no genetically influenced differences among unexposed individuals when in(activated/nonactivated) enzyme activities were compared. The technique is suitable for use in screening for lead poisoning in humans.
Language of Publication
English
Unique Identifier
77089786

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Erythrocytes|*EN; Hydro-Lyases|*BL; Lead Poisoning|*DI/*EN; Porphobilinogen Synthase|*BL
MeSH Heading
Cadmium|PD; Edetic Acid|PD; Enzyme Activation|DE; Glutathione|PD; Human; Kinetics; Lead|BL/PD; Mercury|PD; Sodium|PD; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0009-9147
Country of Publication
UNITED STATES

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Comparative studies on cholesterol oxidases from different sources.
Author
Noma A; Nakayama K
Address
 
Source
Clin Chim Acta, 1976 Dec, 73:3, 487-96
Abstract
1. Comparison of the characteristics of cholesterol oxidases from different sources was made by a new polarographic method for measurement of the oxygen-consumption rate. 2. A pH optimum of 7.0 was observed for cholesterol oxidases isolated from Nocardia and Brevibacterium, pH 5.0 for the enzyme from Schizophyllum and pH 7.5 for the enzyme from Streptomyces. 3. In the system used in the present study, Ca2+ and Mg2+ had no effect on these enzyme activities. On the other hand, the Schizophyllum enzyme was strongly inhibited by increasing concentrations of Cu2+, whereas the brevibacterium enzyme was slightly activated by them and Nocardia and Streptomyces enzymes were not affected. Hg2+ strongly inhibited the activities of enzymes the Schizophyllum enzyme. 4. Using serum as substrate, the cholesterol oxidases employed, except for the enzyme from Streptomyces, were not active without detergent in the reaction mixture. Effects of various detergents at various concentrations on the enzyme activities were studied. 5. Results of studies on the reaction of cholesterol oxidases on free cholesterol in low-and high-density lipoproteins were also compared.
Language of Publication
English
Unique Identifier
77067450

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cholesterol|*BL; Hydroxysteroid Dehydrogenases|*ME
MeSH Heading
Brevibacterium|EN; Calcium|PD; Comparative Study; Copper|PD; Detergents|PD; Edetic Acid|PD; Human; Hydrogen-Ion Concentration; Kinetics; Magnesium|PD; Mercury|PD; Nocardia|EN; Osmolar Concentration; Schizophyllum|EN; Species Specificity; Streptomyces|EN

Publication Type
JOURNAL ARTICLE
ISSN
0009-8981
Country of Publication
NETHERLANDS

Record 15 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Cathepsins B1 from human fetal membranes.
Author
Warwas M; Dobryszycka W
Address
 
Source
Biochim Biophys Acta, 1976 Apr, 429:2, 573-80
Abstract
Cathepsins B1 (EC 3.4.22.1) were isolated from fetal membranes of human placenta, i.e. amnion and chorion-decidua. Purification of the enzymes was achieved by the freezing-thawing technique, ammonium sulphate fractionation and Sephadex gel filtration. Cathepsis B1 separated either from amnion or from chorion-decidua exhibited optimum activity at pH 6.2, and an optimum temperature between 42-45 degrees C. They were inhibited by heavy metals, and compounds which react with the thiol groups. Isoelectric focusing demonstrated three isoenzymes of cathepsin B1 originating from chorion-decidua, while only one band was found for the enzyme from amnion.
Language of Publication
English
Unique Identifier
76161400

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Amnion|*EN; Cathepsins|IP/*ME; Chorion|*EN; Fetal Membranes|*EN
MeSH Heading
Cations, Divalent; Edetic Acid|PD; Female; Human; Hydrogen-Ion Concentration; Hydroxymercuribenzoates|PD; Iodoacetates|PD; Kinetics; Mercury|PD; Organ Specificity; Pregnancy

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Record 16 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Lead poisoning from Indian herbal medicine (Ayurveda) [see comments]
Author
Dunbabin DW; Tallis GA; Popplewell PY; Lee RA
Address
Flinders Medical Centre, Bedford Park, Sa.
Source
Med J Aust, 1992 Dec, 157:11-12, 835-6
Abstract
OBJECTIVE: To present a case of lead poisoning following ingestion of Indian herbal medicine. CLINICAL FEATURES: A 37-year-old man presented with a history of abdominal pain, anorexia and malaise. He had recently returned from a trip to India where he had been taking two different herbal tonics. Investigation revealed low-grade hepatitis and normocytic anaemia with prominent basophilic stippling. The blood lead concentration was high, and analysis of the herbal tablets revealed a very high lead content. INTERVENTION AND OUTCOME: The patient required narcotic analgesia for abdominal pain and was treated with chelation therapy with calcium ethylenediaminetetra-acetate (calcium EDTA) for five days which resulted in a high urinary excretion of lead and resolution of his symptoms over a period of several days. CONCLUSION: Lead poisoning in Australia is usually the result of chronic industrial exposure, but practitioners should be aware of the possibility of poisoning from other domestic sources such as unglazed pottery, cosmetics and herbal remedies, especially those from Asia and India, in which lead may be present in high concentration. Patients from Asia who present with unexplained anaemia or abdominal symptoms should be asked about exposure to such sources.
Language of Publication
English
Unique Identifier
93086568

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Lead Poisoning|*ET; Medicine, Ayurvedic|*; Medicine, Herbal|*; Plants, Medicinal|*/CH
MeSH Heading
Adult; Arsenic|AN; Case Report; Human; Lead|AN; Male; Mercury|AN

Publication Type
JOURNAL ARTICLE
ISSN
0025-729X
Country of Publication
AUSTRALIA

Record 17 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric detector.
Author
Alton KB; Hernandez A; Alvarez N; Patrick JE
Address
Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Bloomfield, NJ 07003.
Source
J Chromatogr, 1992 Sep, 579:2, 307-17
Abstract
A high-performance liquid chromatographic assay for the determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine (SCH 42354; II), the active metabolite of the atriopeptidase inhibitor prodrug, N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methi onine ethyl ester (SCH 42495; I), in human plasma was validated for use in clinical pharmacokinetic studies. Plasma (200 microliters) was processed by protein precipitation with acetone containing the internal standard, N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L- ethionine (III). Compound II was recovered (ca. 90%) in the supernatant after centrifugation and prepared for injection by the addition of 0.15 M monochloroacetic acid containing 0.2 mM EDTA. Separation of II and III was accomplished on commercially available reversed-phase C8 columns designed for the separation of basic compounds. Both compounds were detected using amperometric detection (+0.125 V versus Ag/AgCl) on a thin-layer Au/Hg amalgam electrode. The lower limit of quantitation was 10 ng/ml, where the inter-assay precision (coefficient of variation) was +/- 11.4% and the inter-assay accuracy (bias) was +1.0%. No endogenous interferences were observed in the extracts obtained from drug-free plasma. The detector response (using either peak area or height ratios of II to III) was linear from 0.01 to 1.0 micrograms/ml. Compound II was stable in plasma supplemented with EDTA and sodium hydrogensulfite for at least 3 months when stored frozen at -78 degrees C; no significant decomposition of II was observed following three freeze-thaw cycles. The feasibility of this liquid chromatographic assay with electrochemical detection was demonstrated with plasma samples from hypertensive subjects administered 100 mg of compound I.
Language of Publication
English
Unique Identifier
93055121

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Chromatography, High Pressure Liquid|*MT; Methionine|*AA/BL/ME; Neprilysin|*AI/BL/ME
MeSH Heading
Gold; Human; Hypertension|BL; Mercury; Sulfhydryl Compounds

Publication Type
JOURNAL ARTICLE
ISSN
0021-9673
Country of Publication
NETHERLANDS

Record 18 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Phosphorylation of the Ca2+ pump intermediate in intact red cells, isolated membranes and inside-out vesicles.
Author
Szász I; Hasitz M; Sarkadi B; Gárdos G
Address
 
Source
Mol Cell Biochem, 1978 Dec, 22:2-3, 147-52
Abstract
Ca2+-entry into intact red cells containing [32P]-ATP increases the phosphorylation of the 150 000 dalton polypeptide of the membrane. This phosphorylation occurs even in Mg2+-depleted red cells. Extracellular lanthanum applied during ATP-depletion further increases the Ca2+-induced phosphorylation. In fragmented membranes or resealed insideout vesicles (IOVs) membrane bound Mg2+ is sufficient to catalyze the phosphorylation of spectrin 2 and Band 3 polypeptides with low concentrations (less than micron of [32P]-ATP. In Ca-EDTA buffers one single polypeptide is phosphorylated which is located in the 150 000 molecular weight region. KmCa for phosphorylation is much lower (0.2 micron) than for active Ca2+ transport (40 micron) in IOVs. Lanthanum induced phosphorylation (up to 250 micron Lafree) is significantly greater than Ca2+-induced phosphorylation. Hg2+ inhibits both Ca2+ and La3+ induced phosphorylation. Ca2+-induced labelling can be rapidly "chased" by unlabelled ATP+Mg2+, but not with EGTA+Mg2+. Dephosphorylation in Ca2+ phosphorylated membranes and IOVs is significantly inhibited by La3+. It can be concluded that the mechanism of La3+ and Hg2+ inhibition of the Ca2+ pump is different in intact cells and isolated membranes or Iovs.
Language of Publication
English
Unique Identifier
79134711

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Calcium|*BL/PD; Erythrocyte Membrane|DE/*ME; Erythrocytes|DE/*ME; Membrane Proteins|*BL; Phosphoproteins|*BL
MeSH Heading
Biological Transport, Active|DE; Human; Lanthanum|PD; Mercury|PD; Phosphorylation

Publication Type
JOURNAL ARTICLE
ISSN
0300-8177
Country of Publication
NETHERLANDS

Record 19 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
A novel approach for heavy metal poisoning treatment, a model. Mercury poisoning by means of chelating microspheres: hemoperfusion and oral administration.
Author
Margel S
Address
 
Source
J Med Chem, 1981 Oct, 24:10, 1263-6
Abstract
The chelating drugs BAL (2,3-dimercaptopropanol), EDTA (ethylenediaminetetraacetic acid), and penicillamine (2-amino-3-mercapto-3-methylbutanoic acid), which are used for metal poisoning, are toxic and there is a real need for alternatives, especially for severe cases. A novel approach for treatment of heavy-metal poisoning is under investigation in our group. The approach utilizes the synthesis of chelating microspheres specific for the desired metallic compound. The microspheres are suggested for use in severe cases by means of hemoperfusion, as a first aid, and then by oral administration. As a model this approach was tried for mercury poisoning. Polymercaptal microspheres of 0.8 micrometer average size were synthesized. The microspheres have a high surface area, have a high affinity toward organic and inorganic mercury compounds, and can compete easily with albumin and cysteine in the ability to bind mercury compounds. These microspheres also were encapsulated with agarose--a blood compatible polymer--and were tried successfully for plasma perfusion (in 10 min, 40% of CH3HgCl and of HgCl2 were removed from 20 ppm of poisoned plasma).
Language of Publication
English
Unique Identifier
82122390

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Chelating Agents|*AD/ME; Hemoperfusion|*; Mercury Poisoning|*TH
MeSH Heading
Administration, Oral; Human; Mercury|ME; Microspheres; Models, Biological

Publication Type
JOURNAL ARTICLE
ISSN
0022-2623
Country of Publication
UNITED STATES

Record 20 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
No evidence of renal toxicity from amalgam fillings [see comments]
Author
Sandborgh Englund G; Nygren AT; Ekstrand J; Elinder CG
Address
Department of Dental Toxicology, Karolinska Institute, Huddinge, Sweden.
Source
Am J Physiol, 1996 Oct, 271:4 Pt 2, R941-5
Abstract
Dental amalgam continuously releases mercury. Studies of sheep [Boyd et al., Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R1010-R1014, 1991] showed decreased renal function after placement of amalgam fillings. In this study, renal function was investigated in 10 healthy volunteers before and after amalgam removal. The subjects had an average of 18 tooth surfaces filled with amalgam, which was removed during one dental session. One week before and sixty days after removal, the glomerular filtration rate (GFR) was determined by 51Cr-EDTA clearance technique. Blood and urine samples were collected for analysis of mercury, creatinine, beta 2-microglobulin, N-acetyl-beta-glucosaminidase (NAG), and albumin 1 wk before and 1, 2, and 60 days after amalgam removal. The plasma mercury concentration increased significantly 1 day after removal. Sixty days later, significantly lower mercury levels were found in blood, plasma, and urine. The GFR values were similar before and after mercury exposure (mean 94 and 94 ml/min per 1.73 m2, respectively). No detectable effects occurred on excretion of NAG, beta 2-microglobulin, or albumin. It is concluded that no signs of renal toxicity could be found in conjunction with mercury released from amalgam fillings.
Language of Publication
English
Unique Identifier
97053473

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Dental Amalgam|*AE; Kidney|*DE; Mercury|*AE/BL
MeSH Heading
beta 2-Microglobulin|UR; Acetylglucosaminidase|UR; Adult; Albuminuria|UR; Creatinine|ME; Female; Glomerular Filtration Rate|DE; Human; Male; Middle Age; Support, Non-U.S. Gov't; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0002-9513
Country of Publication
UNITED STATES

Record 21 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
The effect of zinc and other divalent cations on the structure and function of human alpha 2-macroglobulin.
Author
Pratt CW; Pizzo SV
Address
 
Source
Biochim Biophys Acta, 1984 Dec, 791:2, 123-30
Abstract
Zinc binding to human alpha 2-macroglobulin was studied to assess its involvement in the structure and function alpha 2-macroglobulin. Equilibrium dialysis experiments indicated multiple classes of zinc-binding sites, the one of highest affinity having a site number of 20 and a Kd value of 8 X 10(-7) M. Native alpha 2-macroglobulin and alpha 2-macroglobulin-trypsin complexes bound comparable amount of zinc. The proteinase inhibitory activity of alpha 2-macroglobulin was not affected by zinc binding at physiological concentrations nor by the removal of zinc by EDTA. Above 25 microM zinc, alpha 2-macroglobulin activity decreased, although binding of [125I]trypsin was not affected. When nondenaturing gel electrophoresis was performed, the preparation of alpha 2-macroglobulin migrated as half-molecules at increasing zinc concentration. Experiments with other divalent cations correlated decreases in alpha 2-macroglobulin activity with apparent dissociation of the alpha 2-macroglobulin tetramer in the presence of copper and mercury, but not barium, cadmium or nickel. While zinc binding to alpha 2-macroglobulin does not function in proteinase inhibition, it might be involved in zinc transport in vivo. At nonphysiological concentrations, zinc and other divalent cations are useful as probes of protein quaternary structure.
Language of Publication
English
Unique Identifier
85072921

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
alpha-Macroglobulins|AI/*ME/PD; Zinc|ME/*PD
MeSH Heading
Binding Sites; Cations, Divalent; Copper|PD; Dialysis; Electrophoresis, Polyacrylamide Gel; Human; Macromolecular Systems; Mercury|PD; Protease Inhibitors|PD; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Trypsin|ME

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Record 22 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Stereoselective hydrolysis of soman in human plasma and serum.
Author
De Bisschop HC; De Meerleer WA; Van Hecke PR; Willems JL
Address
Technical Division of the Army, Department for Nuclear, Biological and Chemical Protection, Vilvoorde, Belgium.
Source
Biochem Pharmacol, 1987 Nov, 36:21, 3579-85
Abstract
The contribution of various human serum and plasma fractions to the total hydrolysis rate constants of the four isomers of soman is studied. Spontaneous hydrolysis (as measured in buffer) occurs at a faster rate for the C(+)P(+)- and C(-)P(-)-isomers. A stereoselectively catalyzed hydrolysis of soman occurs in serum fractions IV and V (albumin). In fraction V the C(+)P(+)- and C(-)P(-)-isomers are hydrolyzed at a faster rate than their respective epimers, while in fraction IV-1 a stereoselective effect towards C(+)P(+)-soman is found. All the forementioned contributions, however, are negligible in comparison with the stereoselective enzymatic hydrolysis of the P(+)-isomers. The latter reaction is characterized by a significant lowering of the activation energy as compared with the spontaneous hydrolysis of the P(+)-isomers. Such a lowering in activation energy is not found for the hydrolysis of the P(-)-isomers in whole serum or plasma; hence it can be concluded that a phosphorylphosphatase hydrolyzes the P(+)-isomers in a stereoselective way, the P(-)-isomers either not being affected by this (these) enzyme(s) or the mechanism of catalysis being fundamentally different. This conclusion is in agreement with the observations on the influence of Hg2+ on the hydrolysis of soman in serum; the hydrolysis of the P(+)-isomers is significantly inhibited by 1 mM of Hg2+ while the P(-)-hydrolysis is unaffected by this concentration of Hg2+. The action of some potential inhibitors on this phosphorylphosphatase activity was studied. Iodoacetate did not inhibit nor did Ba2+, Sr2+, Co2+ or Mn2+ show a significant effect on the hydrolysis of the P(+)-isomers. On the other hand the hydrolytic activity in serum was nearly completely inhibited by EDTA but restored upon addition of Ca2+. These findings suggest that this enzymatic activity can be classified as an arylesterase (paraoxonase). Finally, the influence of pH on the hydrolytic activity shows a different pattern for C(+)P(+)- and C(-)P(+)-soman, which may suggest that more than one enzyme is involved in the degradation of soman.
Language of Publication
English
Unique Identifier
88049757

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Soman|*BL
MeSH Heading
Calcium|PD; Human; Hydrogen-Ion Concentration; Hydrolysis; Mercury|PD; Stereoisomerism; Tromethamine

Publication Type
JOURNAL ARTICLE
ISSN
0006-2952
Country of Publication
ENGLAND

Record 23 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Author
Aposhian HV; Maiorino RM; Gonzalez Ramirez D; Zuniga Charles M; Xu Z; Hurlbut KM; Junco Munoz P; Dart RC; Aposhian MM
Address
Department of Molecular and Cellular Biology, University of Arizona, Tucson 85721, USA.
Source
Toxicology, 1995 Mar, 97:1-3, 23-38
Abstract
Four chelating agents that have been used most commonly for the treatment of humans intoxicated with lead, mercury, arsenic or other heavy metals and metalloids are reviewed as to their advantages, disadvantages, metabolism and specificity. Of these, CaNa2EDTA and dimercaprol (British anti-lewisite, BAL) are becoming outmoded and can be expected to be replaced by meso-2,3-dimercaptosuccinic acid (DMSA, succimer) for treatment of lead intoxication and by the sodium salt of 2,3-dimercapto-1-propanesulfonic acid (DMPS, Dimaval) for treating lead, mercury or arsenic intoxication. Meso-2,3-DMSA and DMPS are biotransformed differently in humans. More than 90% of the DMSA excreted in the urine is found in the form of a mixed disulfide in which each of the sulfur atoms of DMSA is in disulfide linkage with an L-cysteine molecule. After DMPS administration, however, acyclic and cyclic disulfides of DMPS are found in the urine. The Dimaval-mercury challenge test holds great promise as a diagnostic test for mercury exposure, especially for low level mercurialism. Urinary mercury after Dimaval challenge may be a better biomarker of low level mercurialism than unchallenged urinary mercury excretion.
Language of Publication
English
Unique Identifier
95232791

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Chelating Agents|*TU; Metals|PK/*PO
MeSH Heading
Animal; Dimercaprol|ME/TU; Edetic Acid|ME/TU; Human; Succimer|ME/TU; Support, U.S. Gov't, P.H.S.; Unithiol|ME/TU

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0300-483X
Country of Publication
IRELAND

Record 24 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.
Author
Hainaut P; Milner J
Address
Department of Biology, University of York, Heslington, United Kingdom.
Source
Cancer Res, 1993 Apr, 53:8, 1739-42
Abstract
In human tumors, many different point mutations of the p53 gene knock out suppressor function and induce the p53 polypeptide to adopt an immunologically distinct, "mutant" conformation. Here we show that exposure to the metal chelator 1,10-phenanthroline induces wild-type p53 to adopt the mutant conformation and that this process is reversible. Conversion to mutant phenotype also occurs after exposure to (a) an organic mercurial reagent targeting cysteinyl residues and (b) low concentrations of mercury or cadmium. We propose that binding of metal ions, most probably zinc, to conserved cysteinyl residues stabilizes the tertiary structure of wild-type p53.
Language of Publication
English
Unique Identifier
93223179

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Metals|*PD; Protein p53|*CH
MeSH Heading
Amino Acid Sequence; Animal; Cysteine|CH; Edetic Acid|PD; Egtazic Acid|PD; Human; Mice; Molecular Sequence Data; Protein Conformation|DE; Rabbits; Support, Non-U.S. Gov't; Zinc|ME/PD

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 25 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.
Author
Hainaut P; Milner J
Address
Department of Biology, University of York, Heslington, United Kingdom.
Source
Cancer Res, 1993 Apr, 53:8, 1739-42
Abstract
In human tumors, many different point mutations of the p53 gene knock out suppressor function and induce the p53 polypeptide to adopt an immunologically distinct, "mutant" conformation. Here we show that exposure to the metal chelator 1,10-phenanthroline induces wild-type p53 to adopt the mutant conformation and that this process is reversible. Conversion to mutant phenotype also occurs after exposure to (a) an organic mercurial reagent targeting cysteinyl residues and (b) low concentrations of mercury or cadmium. We propose that binding of metal ions, most probably zinc, to conserved cysteinyl residues stabilizes the tertiary structure of wild-type p53.
Language of Publication
English
Unique Identifier
93223179

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Metals|*PD; Protein p53|*CH
MeSH Heading
Amino Acid Sequence; Animal; Cysteine|CH; Edetic Acid|PD; Egtazic Acid|PD; Human; Mice; Molecular Sequence Data; Protein Conformation|DE; Rabbits; Support, Non-U.S. Gov't; Zinc|ME/PD

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 26 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Lead poisoning with pigmentation of the oral mucosa. Review of the literature and report of a case.
Author
ten Bruggenkate CM; Lopes Cardozo E; Maaskant P; van der Waal I
Address
 
Source
Oral Surg Oral Med Oral Pathol, 1975 May, 39:5, 747-53
Abstract
Some general aspects of the pathogenesis and the clinical and oral symptoms of chronic lead intoxication are presented. Treatment procedures are briefly discussed. The case of a patient suffering from plumbism is described. A typical Burtonian line was present in the mouth. By electron microprobe analysis, it was shown that this line was mainly the result of lead and, to a minor extent, the result of mercury-, copper-, and iron-bearing pigment in the subepithelial tissue.
Language of Publication
English
Unique Identifier
75195263

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Gingival Diseases|*CI; Lead Poisoning|*CO/DI/DT; Pigmentation Disorders|*CI
MeSH Heading
Adult; Biopsy; Calcium|AD/TU; Edetic Acid|AD/TU; Human; Injections, Intravenous; Male

Publication Type
JOURNAL ARTICLE
ISSN
0030-4220
Country of Publication
UNITED STATES

Record 27 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Human erythrocyte pyrimidine nucleoside monophosphate kinase. Partial purification and properties of two allelic gene products.
Author
Teng YS; Chen SH; Scott CR
Address
 
Source
J Biol Chem, 1976 Jul, 251:14, 4179-83
Abstract
Human pyrimidine nucleoside monophosphate kinase is a polymorphic enzyme having two allelic gene products, UMPK 1 and UMPK 2, in several populations. A procedure is described for the partial purification of this enzyme from human red blood cells resulting in a 1500-fold purification of the enzyme for UMPK 1 and 583-fold for UMPK 2. The purified enzyme preparation catalyzed the phosphorylation of UMP, CMP, and dCMP, and used ATP as the preferred phosphate donor. The heavy metals, mercury, and copper, were found to be strong inhibitors of pyrimidine nucleoside monophosphate kinase activity. EDTA was found to protect the enzyme from inactivation by the heavy metals, and 2-mercaptoethanol stabilized the enzyme during purification. UMPK 1 and UMPK 2 were found to have similar kinetic properties; however, UMPK 2 had a slower electrophoretic mobility and greater thermolability than UMPK 1.
Language of Publication
English
Unique Identifier
76213295

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Alleles|*; Erythrocytes|*EN; Isoenzymes|*BL; Phosphotransferases|*BL/IP; Polymorphism (Genetics)|*
MeSH Heading
Cations, Divalent; Drug Stability; Heat; Human; Kinetics; Structure-Activity Relationship; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES

Record 28 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Recent advance in the therapy of metal poisonings with chelating agents.
Author
Aaseth J
Address
 
Source
Hum Toxicol, 1983 Apr, 2:2, 257-72
Abstract
1 A survey is given of the use of chelating agents in the treatment of metal poisonings. 1 The complexing agents in established clinical use are the polyaminopolycarboxylic acid EDTA (ethylenediamine tetraacetate) and the thiols BAL (2, 3-dimercaptopropanol) and D-penicillamine. Desferrioxamine is useful in the treatment of iron overloading. 2 The theoretical foundation of the metal-ligand interaction and some general principles of value in the search for new metal antidotes are outlined. 3 Recent research has shown that 2, 3-dimercaptosuccinic acid (DMS) and 2, 3-dimercaptopropane-1-sulphonate (DMPS) are effective in mercury and arsenic poisonings. 4 DMS and DMPS are of significantly lower toxicity than BAL, and they can be administered orally or intravenously. 5 A particularly low toxicity of DMS is reported from clinical and experimental studies, and this agent may be useful against several metal poisonings including mercury, lead and gold.
Language of Publication
English
Unique Identifier
83236439

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Chelating Agents|ME/TO/*TU; Metals|*PO
MeSH Heading
Animal; Brain|ME; Chemistry; Drug Stability; Human; Kinetics; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0144-5952
Country of Publication
ENGLAND

Record 29 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Prevention by chelating agents of metal-induced developmental toxicity.
Author
Domingo JL
Address
Laboratory of Toxicology and Biochemistry, School of Medicine, Rovira i Virgili University, Reus, Spain.
Source
Reprod Toxicol, 1995 Mar, 9:2, 105-13
Abstract
Chelating agents such as calcium disodium ethylenediaminetetraacetate (EDTA), 2,3-dimercaptopropanol (BAL), or D-penicillamine (D-PA) have been widely used for the past 4 decades as antidotes for the treatment of acute and chronic metal poisoning. In recent years, meso-2,3-dimercaptosuccinic acid (DMSA), sodium 2,3-dimercapto-1-propanesulfonate (DMPS) and sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) have also shown to be effective to prevent against toxicity induced by a number of heavy metals. The purpose of the present article was to review the protective activity of various chelating agents against the embryotoxic and teratogenic effects of well-known developmental toxicants (arsenic, cadmium, lead, mercury, uranium, and vanadium). DMSA and DMPS were found to be effective in alleviating arsenate- and arsenite-induced teratogenesis, whereas BAL afforded only some protection against arsenic-induced embryo/fetal toxicity. Also, DMSA, DMPS, and Tiopronin were effective in ameliorating methyl mercury-induced developmental toxicity. Although the embryotoxic and teratogenic effects of vanadate were significantly reduced by Tiron, no significant amelioration of uranium-induced embryotoxicity was observed after treatment with this chelator.
Language of Publication
English
Unique Identifier
95315648

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Abnormalities, Drug-Induced|*PC; Chelating Agents|*TU; Fetal Development|*DE; Metals|*PO/TO
MeSH Heading
Animal; Female; Human; Pregnancy

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0890-6238
Country of Publication
UNITED STATES

Record 30 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection.
Author
Rabel SR; Stobaugh JF; Trueworthy R
Address
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66045.
Source
Anal Biochem, 1995 Jan, 224:1, 315-22
Abstract
Capillary electrophoresis proved to be a useful technique for the analysis of intracellular levels of 6-thioguanosine mono-, di-, and triphosphate with analysis times of 20 min. Conditions required for baseline separation of the thioguanine nucleotides consisted of a 25 mM KH2PO4 (pH 8.0) buffer and a separation voltage of +28 kV. Laser-induced fluorescence detection (lambda ex = 325 nm, lambda em = 410 nm) of the thioguanine nucleotide metabolites of 6-mercaptopurine (6-MP) was possible following oxidation of the thiol functionality. Tedious extraction procedures involving mercury cellulose resins or phenyl mercury adduct formation, which had been required previously for the selective extraction of thiopurines from erythrocytes, were unnecessary due to the overall specificity of the approach. However, the inclusion of 50 mM EDTA in the sample preparation was required to inhibit the anabolic/catabolic enzymatic activity, which was responsible for the degradation of the analytes. The method demonstrated linearity from 5 to 1700 pmol/100 microliters red blood cells for the three analytes (RSDs < or = 8%). The feasibility of the method was demonstrated for the quantitation of 6-thioguanine nucleotides in patients receiving either oral or intravenous 6-MP therapy.
Language of Publication
English
Unique Identifier
95225456

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Erythrocytes|*CH; Guanine Nucleotides|*BL; Guanosine Diphosphate|*AA/BL; Guanosine Triphosphate|*AA/BL; Thionucleotides|*BL; 6-Mercaptopurine|*ME
MeSH Heading
Electrophoresis; Fluorescence; Human; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0003-2697
Country of Publication
UNITED STATES

Record 31 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Metal-binding characteristics of the parotid salivary protein gustin.
Author
Shatzman AR; Henkin RI
Address
 
Source
Biochim Biophys Acta, 1980 May, 623:1, 107-18
Abstract
Metal binding characteristics of the parotid salivary protein gustin have been examined. When purified to apparent homogeneity, gustin contains 1 gatom Zn/mol which is tightly bound (Kd at pH 7.2, 4.5--10(-11) M). This tightly bound zinc can be removed with strong chelators such as diethyldithiocarbamic acid and 1,10-o-phenanthroline at pH 4.5, but not with EDTA or Chelex 100. Removal of the metal ion causes no appreciable conformational change in the protein. The apoprotein can be reconstituted by dialysis against Zn2+-containing buffer, a process favored by pH greater than 6.0. Only cobalt is able to bind to the apoprotein at this strong binding site. Cobalt binding is appreciably weaker than that of zinc (Kd at pH 7.2, 1.3--10(-7) M) and is maximal at pH 7.0. The weaker binding of cobalt is also illustrated by the loss of 37% of bound cobalt after 96 h of dialysis at pH 7.2, conditions under which the zinc content of gustin does not change. A second gatom Zn/mol may be loosely bound to gustin, but is easily removed by dialysis against metal ion-free buffer. Other metal ions such as copper, nickel, iron or manganese, but not cadmium or mercury, bind loosely to this second zinc site and are removed with ease. Zinc appears to be involved in the formation of the complex between gustin and glycoproteins which are present in human parotid saliva in vivo.
Language of Publication
English
Unique Identifier
80198516

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Parotid Gland|*ME; Salivary Proteins|*ME; Zinc|*ME
MeSH Heading
Ageusia|PP; Apoproteins|ME; Chromatography, Gel; Circular Dichroism; Cobalt|ME; Glycoproteins|ME; Human; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Return To Top
Return To Menu Position #20
Return To Menu Position #30


We subscribe to the HONcode principles
of the Health On the Net Foundation

If you missed it, you can go to either a SHORT explanation of the whole story, or a detailed explanation on ONE PAGE.  On this page you are getting more detail on one part of the story, but on either of those pages you can get the broad picture.  Don't miss reading one of them.  You can actually spend many hours on this web site, depending on the depth of research and reading you want to do.  There are an amazing 4,000 pages here -- more information on these general subjects than almost all other web sites combined!  At some point along the way you will probably say, "Karl's crazy," and leave never to return to this site, or you will say "I want to try some of that oral chelation formula he writes about!"

 


Special Pages On The Various of 12 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.